REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Boryung Corporation (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Boryung Corporation Profile Updated: June 25, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Boryung Corporation is a pharmaceutical company specializing in the development and manufacturing of vital medicines. The company's pharmaceutical business recorded sales of 859.6 billion KRW and an operating profit of 68.3 billion KRW. Boryung Corporation leads the domestic production of essential cancer drugs and is exploring opportunities for national self-sufficiency in essential medicine.

Headquarters
66-21 Boryung Building, Wonnahm-Dong, Jongno-Gu
Seoul; Seoul; Postal Code: 110-750

Contact Details: Purchase the Boryung Corporation report to view the information.

Website: http://www.boryung.co.kr

Basic Information
Total Employees:
Purchase the Boryung Corporation report to view the information.
Outstanding Shares:
Purchase the Boryung Corporation report to view the information.
Registered Capital:
Purchase the Boryung Corporation report to view the information.
Financial Auditors:
Purchase the Boryung Corporation report to view the information.
Incorporation Date:
November 11, 1963
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
12.16%
Purchase this report to view the information.
5.33%
Purchase this report to view the information.
1.39%
Subsidiaries
Medience Co., Ltd.
Company Performance
Financial values in the chart are available after Boryung Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
1.56%▲
Total operating revenue
1.92%▲
Operating Profit/Loss (EBIT)
22.73%▲
EBITDA
14.64%▲
Net Profit/Loss for the Period
-23.38%▼
Total Assets
34.35%▲
Total Equity
36.6%▲
Operating Profit Margin (ROS)
1.44%▲
Net Profit Margin
-1.82%▼
Return on Equity (ROE)
-4.14%▼
Debt/Equity
9.77%▲
Quick Ratio
0.59%▲
Cash Ratio
0.15%▲

Similar companies

Cj Cheiljedang Corporation
 
Kt&G Corporation
Amore Pacific Group
 
Samsung Biologics Co., Ltd.
Green Cross Holdings Corporation
 
Yuhan Corporation
Jeil Pharma Holdings Inc.
 
Huons Global Co.,Ltd.
Msd Korea Ltd.
 
MJ Pharm Co., Ltd.
Jw Pharmaceutical Co.,Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo